Answers are grounded in this paper and cite their sources.
Intrahepatic cholangiocarcinoma is an aggressive liver cancer with limited treatment options. NSUN4 supports mitochondrial protein synthesis, but its role in this cancer remains unclear. We investigated its clinical relevance and biological function. We analyzed public gene-expression datasets, 43 tumor specimens, 37 non-tumorous bile duct specimens, and survival data from 34 patients. NSUN4 depletion and rescue experiments were performed in two cancer cell lines. Tumor growth and lung colonization were assessed in male BALB/c nude mice (eight per group). Statistical analyses included analysis of variance, nonparametric tests, log-rank tests, and Cox regression. Here we show that NSUN4 expression is elevated in tumors and associated with unfavorable clinical features and shorter survival. NSUN4 depletion suppresses cell proliferation, migration, invasion, tumor growth, and lung colonization. It also reduces mitochondrial ribonucleic acid methylation, impairs mitochondrial protein synthesis and energy production, and increases susceptibility to cisplatin-induced cell death. Wild-type NSUN4 restores selected respiratory-chain protein levels, cell proliferation, and migration more effectively than a catalytic-site mutant. NSUN4 supports mitochondrial protein synthesis and energy metabolism in intrahepatic cholangiocarcinoma. These findings support further investigation of NSUN4 as a potential prognostic marker and therapeutic target.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: